Apheresis Clinical Trial
Official title:
Apheresis Procedures to Obtain Plasma or Leukocytes for In Vitro Studies
This study will collect blood plasma and white blood cells from individuals using a procedure
called apheresis. Apheresis is a method of collecting larger quantities of certain blood
components than can safely be collected through a simple blood draw or blood donation
process. The blood components will be used in laboratory research studies to investigate
aspects of infectious and immunologic allergic diseases.
Patients 7 years of age and older who are currently enrolled in a NIH clinical research
protocol may participate in this study. (Children between the ages of 2 and 6 may participate
if they will benefit clinically from undergoing apheresis.) Family members of patients and
normal healthy volunteers will also be enrolled.
- For all adults and children weighing 55 pounds or more. Blood is drawn through a needle
placed in an arm vein and circulated through a cell separator machine. The plasma and
white cells are extracted, and the red cells are returned to the donor through a needle
in the other arm. The procedure takes from 1 to 2 hours.
- For children weighing less than 55 pounds. One unit (1 pint) of blood is drawn through a
needle placed in an arm vein, similar to donating a pint of whole blood. The red blood
cells are separated from the rest of the blood and returned to the donor through the
same needle. This procedure requires only one needlestick and takes about 30 to 45
minutes to complete. In some circumstances, the procedure must be repeated one or more
times in order to obtain large enough quantities of plasma or cells for study.
In order to carry out in vitro research procedures on the plasma or leukocyte components of blood, it is often necessary to obtain larger quantities of plasma or leukocytes than can be safely obtained by simple phlebotomy. These components can be easily and safely obtained using apheresis procedures performed in the Apheresis Clinic of the Department of Transfusion Medicine, Clinical Center. This protocol is specifically designed to conform to the requirements of the Apheresis Clinic for donors to have apheresis procedures, but the protocol in itself is not a research protocol. Patients must first be admitted to another approved clinical research protocol of the NIAID before they may have the apheresis procedures described in this protocol. Family members and healthy volunteers may undergo apheresis using only this protocol, without the necessity for entry into any other protocol. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04846374 -
Two is Better Than One: A Novel Venous Access System for Intermittent Apheresis
|
||
Completed |
NCT00042627 -
Prevalence and Risk of Cataracts in Granulocyte Donors
|
N/A | |
Completed |
NCT05191290 -
Comparison of Biocompatibility of Plasmapheresis Procedures With Citrate and Heparin Anticoagulation
|
Phase 4 | |
Recruiting |
NCT00001846 -
Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
|
||
Recruiting |
NCT04939805 -
CRP Apheresis in STEMI
|
N/A |